ND-011992 is a reversible, selective quinazoline-type inhibitor targeting quinone reductases and quinol oxidases . ND-011992 inhibits respiratory complex I and bo 3 oxidase in addition to bd-I and bd-II oxidases in E. coli strain BL21*Δcyo with the IC 50 of 0.12, 2.47, 0.63 and 1.3 μM, respectively. ND-011992 can be used for tuberculosis study.
Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Mitochondrial Metabolism | Products > Signaling Pathways > Bacterial
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.